Adaptive Biotechnologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. 

CEO
Chad Robins
CEOChad Robins
Employees
624
Employees624
Headquarters
Seattle, Washington
HeadquartersSeattle, Washington
Founded
2009
Founded2009
Employees
624
Employees624

ADPT Key Statistics

Market cap
2.11B
Market cap2.11B
Price-Earnings ratio
-34.39
Price-Earnings ratio-34.39
Dividend yield
Dividend yield
Average volume
2.12M
Average volume2.12M
High today
$14.06
High today$14.06
Low today
$13.39
Low today$13.39
Open price
$13.95
Open price$13.95
Volume
1.37M
Volume1.37M
52 Week high
$20.76
52 Week high$20.76
52 Week low
$6.77
52 Week low$6.77

Stock Snapshot

With a market cap of 2.11B, Adaptive Biotechnologies(ADPT) trades at $13.71. The stock has a price-to-earnings ratio of -34.39.

During the trading session on 2026-04-08, Adaptive Biotechnologies(ADPT) shares reached a daily high of $14.06 and a low of $13.39. At a current price of $13.71, the stock is +2.4% higher than the low and still -2.5% under the high.

Trading volume for Adaptive Biotechnologies(ADPT) stock has reached 1.37M, versus its average volume of 2.12M.

Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $20.76 and a low of $6.77.

Over the past 52 weeks, Adaptive Biotechnologies(ADPT) stock has traded between a high of $20.76 and a low of $6.77.

ADPT News

Simply Wall St 2d
Adaptive Biotechnologies Is Up 15.3% After Beating Q4 Views And Striking Pfizer Deals

In early 2026, Adaptive Biotechnologies reported fourth-quarter 2025 earnings that exceeded analyst expectations, highlighted by strong Minimal Residual Disease...

Adaptive Biotechnologies Is Up 15.3% After Beating Q4 Views And Striking Pfizer Deals
Simply Wall St 3d
A Look At Adaptive Biotechnologies Valuation After Strong 1 Year Share Price Performance

Advertisement Why Adaptive Biotechnologies Is On Investors’ Radar Adaptive Biotechnologies (ADPT) has drawn attention after a strong 1 year total return of 98...

A Look At Adaptive Biotechnologies Valuation After Strong 1 Year Share Price Performance

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ADPT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.